Myomo MYO
NYSE MYO
$1.61 -0.01 (-0.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

Myomo (MYO) Gains from Sales and Divestitures (2019 - 2021)

Updated

Myomo's Gains from Sales and Divestitures came in at -$202.00 for FY2021, compared with -$547.00 in FY2020.

Analysis

Myomo (MYO) Gains from Sales and Divestitures (2019 - 2021) Analysis & Trends

  • Per Business Quant, earlier years put Gains from Sales and Divestitures at -$547.00 in FY2020 and -$2,481 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Myomo 61.88 Mn 2.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -202.00
Dec 31, 2020 -370.00
Jun 30, 2019 -2,161.00
Mar 31, 2019 -320.00
API Access

Myomo Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=MYO&period=max&api_key=YOUR_API_KEY